No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
No Data
No Data
No Data
Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders
Yahoo FinanceMar 27 08:42 ET
Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call
Yahoo FinanceMar 25 17:00 ET
Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice
Yahoo FinanceMar 21 08:41 ET
No Data
No Data